Clinical trials
Multiple Sclerosis, Relapsing-Remitting trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 10 |
| 2023 | 5 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tehran University of Medical Sciences | 4 |
| University Hospital Muenster | 3 |
| Amsterdam UMC, location VUmc | 2 |
| Novo Cellular Medicine Institute LLP | 2 |
| Alabama Neurology Associates, PC | 1 |
| American University of Beirut Medical Center | 1 |
| Amphia Hospital | 1 |
| Artielle ImmunoTherapeutics | 1 |
| Assiut University | 1 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 57 |
| Multiple Sclerosis | 29 |
| Multiple Sclerosis, Chronic Progressive | 9 |
| Demyelinating Diseases | 2 |
| Disease Progression | 2 |
| Inflammation | 2 |
| Ataxia | 1 |
| Autoimmune Diseases | 1 |
| Epstein-Barr Virus Infections | 1 |
| Erectile Dysfunction | 1 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.